GABELLI FUNDS LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2017$2,037,000
-4.4%
1,501,0000.0%0.01%
-7.7%
Q1 2017$2,131,000
-25.7%
1,501,000
-26.8%
0.01%
-23.5%
Q4 2016$2,868,000
+18.6%
2,051,0000.0%0.02%
+21.4%
Q3 2016$2,418,000
+172.0%
2,051,000
+95.1%
0.01%
+180.0%
Q2 2016$889,000
+5.1%
1,051,0000.0%0.01%0.0%
Q1 2016$846,000
+82.7%
1,051,000
+110.2%
0.01%
+66.7%
Q4 2015$463,000500,0000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 16,000,000$14,400,0002.99%
Mohican Financial Management, LLC 3,500,000$3,097,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 34,000,000$29,918,0001.09%
QVT Financial LP 9,000,000$8,025,0000.41%
WOLVERINE ASSET MANAGEMENT LLC 13,250,000$11,583,0000.24%
ADVENT CAPITAL MANAGEMENT /DE/ 16,919,000$14,893,0000.23%
DINSMORE CAPITAL MANAGEMENT CO/NJ 500,000$452,0000.18%
CSS LLC/IL 1,000,000$877,0000.04%
Jefferies Group LLC 1,500,000$1,328,0000.01%
CREDIT AGRICOLE S A 2,151,000$1,904,0000.01%
View complete list of ARRAY BIOPHARMA INC shareholders